Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine
Reference30 articles.
1. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB (2008) One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumours in 35,825 cases in the United States. J Clin Oncol 20:3063–3072
2. Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB, Chirieac LR, Dacic S, Duhig E, Flieder DB, Geisinger K, Hirsch FR, Ishikawa Y, Kerr KM, Noguchi M, Pelosi G, Powell CA, Tsao MS, Wistuba I, WHO Panel (2015) The 2015 World Health Organization Classification of Lung Tumors: impact of genetic, clinical and radiologic advances Since the 2004 classification. J Thorac Oncol 10(9):1243–1260
3. Thomas CF, Tazelaar HD, Jett JR (2001) Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest 119:1143–1150
4. The IASLC Lung Cancer Staging Project (2008) Proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 3:1213–1223
5. Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, Muguruza I (2015) ENETS consensus conference participants. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol 26(8):1604–1620
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献